G
Gauss Surgical
The world's first real-time monitoring system for surgical blood loss
About Gauss Surgical
Gauss Surgical, established in 2011, developed a platform to address the critical unmet need for accurate, real-time measurement of blood loss in surgical and obstetric settings. The company was founded by Siddarth Satish, who was inspired to create a technological solution after observing the imprecise visual estimation methods used in operating rooms. Satish, who holds degrees in Chemical Engineering and Bioengineering, founded the company after his graduate work at UC Berkeley and UCSF and a fellowship at Stanford University School of Medicine, where he identified the opportunity to apply computer vision to this longstanding clinical challenge.
The company's flagship product, Triton, is an artificial intelligence-powered platform that uses a mobile device's camera, initially an iPad or iPhone, to scan surgical sponges and fluid-filled canisters. Its computer vision and machine learning algorithms then analyze the images to provide clinicians with an accurate, real-time quantification of a patient's blood loss. This system was designed to replace subjective visual guesswork, which is notoriously inaccurate and can lead to delayed intervention in hemorrhage situations, a leading cause of preventable maternal mortality. By providing precise data, Triton enables earlier recognition of hemorrhage, leading to more timely and appropriate blood transfusions, which can improve patient outcomes and reduce hospital stays.
Gauss Surgical operated on a software-as-a-service (SaaS) business model, providing its HIPAA-compliant platform to hospitals and health systems. The company achieved significant milestones, including receiving De Novo clearance from the U.S. Food and Drug Administration (FDA) in 2014, marking it as the first computer vision software approved for surgical use. It also secured CE Mark approval in Europe and won an Apple Design Award. The company raised substantial venture capital, including a $20 million Series C round in 2018 with investments from strategic partners like Northwell Health and SoftBank Ventures Korea, to accelerate adoption and development. In a strategic move to broaden its impact, medical technology giant Stryker acquired Gauss Surgical in September 2021.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Employees
- 7
- Open positions
- None listed
- Dealroom signal
- 61.6/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotechnology, Surgery, Core AI, Spinout, AI Applications, DT and LS, science-based
- Technology
- Artificial Intelligence, Deep Tech
- Business model
- SaaS
- Client focus
- B2C
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Sep 2021 | $0 | — | Stryker | — |
| SERIES COther financing | Oct 2020 | $10M | $100M | Polaris Partners · OSF · The 4100 Group · SBVA | — |
Growth signals
Latest recorded traffic for Gauss Surgical is 620 monthly website visits, up 244.4% over the last three months. Gauss Surgical's team declined 12.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Gauss Surgical in the Menlo Park ecosystem
The Gauss Surgical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Promus Ventures
Series A5 investors entered at this stage
StartX
Summation Health Ventures- LVLifeforce Ventures
Providence Ventures
Jump Capital
Series B and later7 investors entered at this stage
SBVA
Northwell Health
Polaris Partners
OSF
Rex Health Ventures
Providence Healthcare Network- TGThe 4100 Group
Other known investors3 additional known investors
Stanford University
Stryker
University of California, San Francisco
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Gauss Surgical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Gauss Surgical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








